Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | +0.57% | +14.59% | -24.27% |
May. 14 | Transcript : NRx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.27% | 36.68M | |
+31.83% | 50.85B | |
+1.34% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+12.28% | 26.11B | |
-21.14% | 19.13B | |
+7.31% | 13.05B | |
+27.56% | 12.16B | |
+23.43% | 12.08B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- NRX Pharmaceuticals Appoints Ira Strassberg as CFO